Vivos Therapeutics Inc.
10/24/2025 | Press release | Distributed by Public on 10/24/2025 15:21
Material Event (Form 8-K)
Item 8.01 Other Information
On October 24, 2025, Vivos Therapeutics, Inc. (the "Company") filed a prospectus supplement to increase the aggregate offering price of the shares (the "Shares") of the Company's common stock, par value $0.0001 per share, issuable pursuant to the At The Market Offering Agreement between the Company and H.C. Wainwright & Co., dated February 14, 2025.
Attached hereto as Exhibit 5.1 to this Current Report is the opinion of Ellenoff Grossman & Schole LLP relating to the legality of the issuance and sale of the Shares.
Vivos Therapeutics Inc. published this content on October 24, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on October 24, 2025 at 21:21 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]